Killing the Kill Switch: Immune Checkpoint Inhibitors in Cancer Immunotherapy
Channel: Science is a Hobby
Date: 2022-06-27

One of the most important functions of the immune system is eliminating cancerous cells before they have the chance of multiplying out of control. But cancerous cells are genetically unstable and can evolve to exploit the regulatory mechanisms of our immune system, saving themselves from destruction. Researchers have unravelled the molecular mechanisms behind this exploitation and developed drugs that turn the tides in the battle against cancer.

Credits:
Thumbnail: Modified version of: de la Roche M, Ritter AT, Angus KL, et al. Hedgehog signaling controls T cell killing at the immunological synapse. Science. 2013;342(6163):1247-1250. doi:10.1126/science.1244689

[C1] Modified version of: de la Roche M, Ritter AT, Angus KL, et al. Hedgehog signaling controls T cell killing at the immunological synapse. Science. 2013;342(6163):1247-1250. doi:10.1126/science.1244689
[C2] Modified version of: Huth J, Buchholz M, Kraus JM, et al. Significantly improved precision of cell migration analysis in time-lapse video microscopy through use of a fully automated tracking system. BMC Cell Biol. 2010;11:24. Published 2010 Apr 8. doi:10.1186/1471-2121-11-24
[C3] Modified version of: Weigelin, B., den Boer, A.T., Wagena, E. et al. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun 12, 5217 (2021). https://doi.org/10.1038/s41467-021-25282-3
[C4] Modified version of: Toné S, Sugimoto K, Tanda K, et al. Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosis. Exp Cell Res. 2007;313(16):3635-3644. doi:10.1016/j.yexcr.2007.06.018
[C5] Modified version of: Lemaître Florent, Carmena Moratalla Ana, Farzam-kia Negar et al. Capturing T Lymphocytes’ Dynamic Interactions With Human Neural Cells Using Time-Lapse Microscopy. Front. Immunol. Published 2021 Apr 22. https://doi.org/10.3389/fimmu.2021.668483
[C6] Modified version of: Marc Bajénoff, Jackson G. Egen, Lily Y. Koo et al. Stromal Cell Networks Regulate Lymphocyte Entry, Migration, and Territoriality in Lymph Nodes. Cell. Published 2006 Dec 1. https://doi.org/10.1016/j.immuni.2006.10.011
[C7] Modified version of: Qi S, Shi H, Liu L, Zhou L, Zhang Z. Dynamic visualization of the whole process of cytotoxic T lymphocytes killing B16 tumor cells in vitro. J Biomed Opt. 2019;24(5):1-7. doi:10.1117/1.JBO.24.5.051413
[C8] Modified version of: Weigelin, B., den Boer, A.T., Wagena, E. et al. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun 12, 5217 (2021). https://doi.org/10.1038/s41467-021-25282-3
[C9] Modified version of: Weigelin, B., den Boer, A.T., Wagena, E. et al. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun 12, 5217 (2021). https://doi.org/10.1038/s41467-021-25282-3

References:
[R1] Kumar BV, Connors TJ, Farber DL. Human T Cell Development, Localization, and Function throughout Life. Immunity. 2018;48(2):202-213. doi:10.1016/j.immuni.2018.01.007
[R2] F. Nina Papavasiliou, David G. Schatz. Somatic Hypermutation of Immunoglobulin Genes. Cell. Published 2002 Apr 19. https://doi.org/10.1016/S0092-8674(02)00706-7
[R3] Buchbinder EI, Desai A. CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. Am J Clin Oncol. 2016;39(1):98-106. doi:10.1097/COC.0000000000000239
[R4] Judith A. Seidel, Atsushi Otsuka, Kenji Kabashima. Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations. Front. Oncol. Published 2018 March 28. https://doi.org/10.3389/fonc.2018.00086
[R5] Zheying Zhang, Manman Lu, Yu Qin et al. Neoantigen: A New Breakthrough in Tumor Immunotherapy. Front. Immunol. Published 2021 Apr 16. https://doi.org/10.3389/fimmu.2021.672356